Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wedege

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Scandinavian Journal of Immunology|March 26, 2013
Meningococcal omp85 in detergent-extracted outer membrane vesicle vaccines induces high levels of non-functional antibodies in miceE Wedege, K Lie, K Bolstad, et al.
NIPH Annals|December 1, 1991
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal diseaseJ H Fredriksen, E Rosenqvist, E Wedege, et al.
Infection and Immunity|February 20, 1999
Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidisE Rosenqvist, A Musacchio, A Aase, et al.
Microbial Pathogenesis|September 1, 1993
A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccineE Rosenqvist, E A Høiby, E Wedege, et al.
Infection and Immunity|April 1, 1989
Genetic diversity of penicillin G-resistant Neisseria meningitidis from SpainP M Mendelman, D A Caugant, G Kalaitzoglou, et al.
Infection and Immunity|April 7, 1998
Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humansB Haneberg, R Dalseg, E Wedege, et al.
Developments in Biological Standardization|April 29, 1998
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvantB Haneberg, R Dalseg, F Oftung, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Scandinavian Journal of Immunology|March 26, 2013
Meningococcal omp85 in detergent-extracted outer membrane vesicle vaccines induces high levels of non-functional antibodies in miceE Wedege, K Lie, K Bolstad, et al.
NIPH Annals|December 1, 1991
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal diseaseJ H Fredriksen, E Rosenqvist, E Wedege, et al.
Infection and Immunity|February 20, 1999
Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidisE Rosenqvist, A Musacchio, A Aase, et al.
Microbial Pathogenesis|September 1, 1993
A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccineE Rosenqvist, E A Høiby, E Wedege, et al.
Infection and Immunity|April 1, 1989
Genetic diversity of penicillin G-resistant Neisseria meningitidis from SpainP M Mendelman, D A Caugant, G Kalaitzoglou, et al.
Infection and Immunity|April 7, 1998
Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humansB Haneberg, R Dalseg, E Wedege, et al.
Developments in Biological Standardization|April 29, 1998
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvantB Haneberg, R Dalseg, F Oftung, et al.
Pageof 6